Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Brigham and Women's Hospital
Boston, Massachusetts
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 148
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| David White | Conflict of Interest | Apnimed Corp. | $20,000 - $39,999 | 2019 |
| Anna Greka | Conflict of Interest | Goldfinch Biopharma, Inc. | $20,000 - $39,999 | 2017 |
| Anna Greka | Conflict of Interest | Goldfinch Biopharma, Inc. | $20,000 - $39,999 | 2017 |
| Paul Yu | Conflict of Interest | Keros Therapeutics | $10,000 - $19,999 | 2018 |
| Peter Caravan | Conflict of Interest | Collagen Medical | $10,000 - $19,999 | 2016 |
| David Walt | Conflict of Interest | Quanterix Corporation | $10,000 - $19,999 | 2018 |
| Oliver Jonas | Conflict of Interest | Keros Therapeutics | $10,000 - $19,999 | 2019 |
| Natasha Frank | Conflict of Interest | Ticeba GmbH | $10,000 - $19,999 | 2018 |
| Gary Curhan | Conflict of Interest | Allena Pharmaceuticals, Inc. | $5,000 - $9,999 | 2017 |
| David Walt | Conflict of Interest | Quanterix Corporation | $5,000 - $9,999 | 2018 |
| Robert Green | Conflict of Interest | Genome Medical, Inc. | $5,000 - $9,999 | 2018 |
| Vijay Kuchroo | Conflict of Interest | Celsius Therapeutics | $0 - $4,999 | 2018 |
| Joseph Italiano | Conflict of Interest | Platelet Biogenesis | $0 - $4,999 | 2016 |
| Joseph Bonventre | Conflict of Interest | Goldfinch Biopharma, Inc. | $0 - $4,999 | 2017 |
| Joseph Italiano | Conflict of Interest | Platelet BioGenesis | $0 - $4,999 | 2017 |
| Jose Halperin | Conflict of Interest | Mellitus, LLC | 2019 | |
| Jerrold Turner | Conflict of Interest | Thelium Therapeutics | 2019 | |
| Shalender Bhasin | Conflict of Interest | Function Promoting Therapies, LLC (DBA Tesvgen, LLC) | 2016 | |
| Harlan Robins | Conflict of Interest | Adaptive Biotechnologies | 2016 | |
| Peter Wayne | Conflict of Interest | Tree of Life Tai Chi Center | 2017 | |
| Benjamin Neale | Conflict of Interest | Deep Genomics, Inc. | 2018 | |
| Sylvie Breton | Conflict of Interest | Kantum Diagnostics, Inc. | 2017 | |
| Peter Caravan | Conflict of Interest | Catalyst Medical | 2016 | |
| Gabriel Gruionu | Conflict of Interest | Felis Medical | 2017 | |
| Jarone Lee | Conflict of Interest | Felis Medical | 2017 | |
| Sebastian Schneeweiss | Conflict of Interest | Aetion, Inc. | 2019 | |
| Jill Goldstein | Conflict of Interest | NeuroPhase Inc. | 2018 | |
| Ronald Garcia Gomez | Conflict of Interest | NeuroPhase Inc. | 2018 | |
| Bruce David Levy | Conflict of Interest | Resolvyx Pharmaceuticals | 2014 | |
| Jonathan Thon | Conflict of Interest | Platelet BioGenesis | 2014 | |
| Charles Serhan | Conflict of Interest | Resolvyx | 2014 | |
| Jose Halperin | Conflict of Interest | Mellitus LLC | 2014 | |
| Michael Brenner | Conflict of Interest | Adheron Therapeutics | 2015 | |
| Francisco Quintana | Conflict of Interest | AnTolRx,Inc | 2018 | |
| Joseph Italiano | Conflict of Interest | Platelet BioGenesis | 2017 | |
| Omid Farokhzad | Conflict of Interest | BIND Biosciences | 2013 | |
| Ravi Jasuja | Conflict of Interest | Function Promoting Therapies, LLC (DBA Tesvgen, LLC) | 2016 | |
| Harlan Robins | Conflict of Interest | Adaptive Biotechnologies | 2016 | |
| Olivier Pourquie | Conflict of Interest | Anagenesis Biotechnologies | 2016 | |
| Bruce Bean | Conflict of Interest | Carica Health, Inc. | 2018 | |
| Pam Silver | Conflict of Interest | General Biologics | 2018 | |
| Anthony Letai | Conflict of Interest | Vivid | 2018 | |
| Peter Caravan | Conflict of Interest | Collagen Medical | 2016 | |
| Peter Caravan | Conflict of Interest | Reveal Pharmaceuticals | 2016 | |
| Peter Caravan | Conflict of Interest | Factor 1A, LLC | 2016 | |
| Eric Gale | Conflict of Interest | Reveal Pharmaceuticals | 2016 | |
| Alexander Green | Conflict of Interest | Quality Interactions, Inc. | 2018 | |
| Gabriel Gruionu | Conflict of Interest | Restore Surgical, LLC | 2016 | |
| Joseph Italiano | Conflict of Interest | Platelet Biogenesis | 2016 | |
| David Milan | Conflict of Interest | LQT Therapeutics | 2017 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.